12 risultati
This application is a 371 of PCT/JP92/01486 filed Nov. 13, 1992.
TECHNOLOGICAL FIELD
The present invention relates to a drug for hepatic diseases, especially an ameliorant for hepatic function and a drug for hepatitis, which contains docosahexaenoic acid as the active ingredient.
BACKGROUND
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
This invention is directed to a fibrinogen-free plasminogen-plasmin-free blood plasma product and to the method of making such a product by the treatment of animal blood plasma or fractionated plasma products with a pure synthetic fumed colloidal silicon dioxide containing siloxan and silanol groups
TECHNICAL FIELD
The present invention relates to a novel liver fat accumulation inhibitory composition, a food additive for liver fat accumulation inhibition, and a method of inhibiting liver fat accumulation.
BACKGROUND ART
It has been considered that fatty liver, which is a disease wherein fat is
FIELD OF THE INVENTION
The present invention is directed towards novel prodrugs of alcohol, amine, and thiol-containing compounds, to their preparation, to their synthetic intermediates, and to their uses. Prodrugs of the invention may be used to deliver drugs to the liver with high tissue
FIELD OF THE INVENTION
The present invention is directed towards novel prodrugs of alcohol, amine, and thiol-containing compounds, to their preparation, to their synthetic intermediates, and to their uses. Prodrugs of the invention may be used to deliver drugs to the liver with high tissue
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight
This application is a .sctn.371 of International Application No. PCT/US2013/069024, filed 8 Nov. 2013, which claims the priority of Indian Patent Application No. 3480/DEL/2012, filed 9 Nov. 2012.
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of acyl coenzyme A: